Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2777 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
EQT AB. (6/22/22). "Press Release: EQT Private Equity to Acquire SPT Labtech, a Fast-growing Laboratory Automation Player Focused on Low-volume Liquid Handling Technology for GBP 650 Million from Battery Ventures". Stockholm. 2022-06-22
AstraZeneca plc. (6/21/22). "Press Release: Eplontersen Met Co-primary and Secondary Endpoints in Interim Analysis of the NEURO-TTRansform Phase III Trial for Hereditary Transthyretin-mediated Amyloid Polyneuropathy (ATTRv-PN)". 2022-06-21
Global Bioenergies S.A.. (6/21/22). "Press Release: Global Bioenergies Secures First Order from Shell for Testing Volumes of Bio-isobutene Derivatives". Paris. 2022-06-21
Valneva S.E.. (6/20/22). "Press Release: Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15". Saint-Herblain & New York, NY. 2022-06-20
Genomatica, Inc.. (6/16/22). "Press Release: Geno and Unilever Launch $120m Venture to Scale Alternative to Palm Oil and Fossil Fuels". San Diego, CA & London. 2022-06-16
Spirea Ltd.. (6/14/22). "Press Release: Spirea Raises £2.4M ($3M) to Develop Antibody Drug Conjugates in Cancer". Cambridge. 2022-06-14
High-Tech Gründerfonds Management GmbH. (6/14/22). "Press Release: Over €400 Million. New High-Tech Gründerfonds Seed Fund Exceeds Expectations". Bonn. 2022-06-14
MorphoSys AG. (6/14/22). "Press Release: MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210". Planegg & South San Francisco, CA. 2022-06-14
Evonetix Ltd.. (6/13/22). "Press Release: Colin McCracken Joins Evonetix as Chief Executive Officer". 2022-06-13
Charm Therapeutics Ltd.. (6/9/22). "Press Release: Charm Therapeutics Launches with a $50 Million Series A Financing to Transform Structure-based Drug Discovery Using Its Proprietary DragonFold AI Technology". London. 2022-06-09
Relation Therapeutics Ltd.. (6/9/22). "Press Release: Relation Therapeutics, the Active-Graph Machine Learning Drug Discovery Company, Names David Roblin as CEO and Lindsay Edwards as CTO". London. 2022-06-09
Forbion Capital Partners. (6/9/22). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund II at €470 Million". Naarden & Munich. 2022-06-09
Metrion Biosciences Ltd.. (6/9/22). "Press Release: Metrion Biosciences Appoints Dr Benedetta Montagnini as Head of European Business Development". Cambridge. 2022-06-09
Peptone Ltd.. (9/9/22). "Press Release: Peptone Closes a $40M Series-A Funding Round Led by F-Prime and Bessemer Venture Partners". London. 2022-06-09
Synklino ApS. (6/8/22). "Press Release: Synklino Completes Series A Raise of EUR 29.8 Million to Advance Clinical Trials of Its Drug Candidate for the Treatment of Cytomegalovirus (CMV)". Copenhagen. 2022-06-08
ImmunOs Therapeutics AG. (6/7/22). "Press Release: ImmunOs Therapeutics Raises $74 Million Series B Financing Round". Schlieren & Gaithersburg, MD. 2022-06-07
Transition Bio, Inc.. (6/2/22). "Press Release: Transition Bio Closes $50 Million Series A Financing to Accelerate Biomolecular Condensate Drug Discovery". Cambridge, MA & Cambridge. 2022-06-02
Transine Therapeutics Ltd.. (5/31/22). "Press Release: Transine Therapeutics Announces Final Closing of Its Seed Round at £13.7m to Accelerate Its Platform and Portfolio Development". Cambridge. 2022-05-31
GSK plc. (5/31/22). "Press Release: GSK to Acquire Clinical-stage Biopharmaceutical Company Affinivax, Inc.". London. 2022-05-31
PharmEnable Ltd.. (5/30/22). "Press Release: PharmEnable Announces Multi-target Collaboration with Denali Therapeutics in Neurodegenerative Disease". Cambridge. 2022-05-30
NRG Therapeutics Ltd.. (5/30/22). "Press Release: NRG Therapeutics Announces £2.68M Innovate UK Award to Develop New Medicines to Treat Parkinson’s and Motor Neuron Disease". 2022-05-30
Evotec SE. (5/30/22). "Press Release: Evotec Adds Cell Therapy Manufacturing Facility with Acquisition of Rigenerand". Hamburg. 2022-05-30
UK Government (Office for Life Sciences). (5/27/22). "Press Release: UK Commits to Life Sciences Cooperation with Sweden". 2022-05-27
Advent Lfie Sciences. (5/26/22). "Press Release: Advent Life Sciences Announces Growth of Investment Team with Three Senior Appointments". London. 2022-05-26
uMotif Ltd.. (5/25/22). "Press Release: uMotif – the Patient-first Data Capture and Decentralized Clinical Trials Platform – Announces $25.5m of New Investment from a Fund Managed by Athyrium Capital Management". London & New York, NY. 2022-05-25
Elsamogen Ltd.. (5/18/22). "Press Release: BGF, Scottish National Investment Bank and Scottish Enterprise Join Forces to Invest £8m in Aberdeen Biologics Company Elasmogen". Aberdeen. 2022-05-18
SwanBio Therapeutics, Inc.. (5/18/22). "Press Release: SwanBio Therapeutics Announces $56 Million Series B Financing to Advance Novel Gene Therapies for Neurological Conditions". Philadeliphia, PA. 2022-05-18
Synexa Life Sciences B.V.. (5/18/22). "Press Release: Synexa Life Sciences Announces Strategic Growth Plans and Strengthening of Its Executive Team". Leiden. 2022-05-18
RQ Biotechnology Ltd.. (5/17/22). "Press Release: RQ Bio Launches with Goal to Transform Treatment and Prevention of Viral Infectious Diseases Through Antibody Technologies". London. 2022-05-17
Thabor Therapeutics S.A.S.. (5/17/22). "Press Release: Thabor Therapeutics Appoints Jérémie Mariau as CEO". Paris. 2022-05-17
Sofinnova Partners. (5/16/22). "Press Release: Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences". New York, NY & Paris. 2022-05-16
Proteros Biostructures GmbH. (5/16/22). "Press Release: Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca". Munich. 2022-05-16
Coulter Partners. (5/13/22). "Press Release: Coulter Partners Expands Its Global Team with Key Appointments and a New Office in Italy". London. 2022-05-13
Domain Therapeutics S.A.. (5/12/22). "Press Release: Domain Therapeutics Raises $42m Series A Financing to Accelerate Clinical Development of Its Best-in-Class and First-in-Class Immuno-oncology Programs". Strasbourg & Montréal, ON. 2022-05-12
Artax Biopharma, Inc.. (5/11/22). "Press Release: Artax Biopharma Closes Financing to Advance Clinical Stage First-in-Class Oral Immunomodulator to Treat T Cell-Mediated Diseases". Cambridge, MA. 2022-05-11
NeoGenomics, Inc.. (5/9/22). "Press Release: NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary". Ft. Myers, FL. 2022-05-09
Discovery Park Ltd.. (5/9/22). "Press Release: Discovery Park Ventures Launches to Drive Disruptive Innovation and Catalyse Regional Growth". Sandwich, Kent. 2022-05-09
Bruker Corporation. (5/9/22). "Press Release: Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets". London. 2022-05-09
Consilium Strategic Communications Ltd.. (5/6/22). "Press Release: Consilium Strategic Communications Appoints Tracy Cheung as Partner". London. 2022-05-06
Sidekick Health. (5/5/22). "Press Release: Sidekick Raises $55M Series B to Drive Further Growth". Berlin, Boston & Reykjavik. 2022-05-05
OMass Therapeutics Ltd.. (4/28/22). "Press Release: OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases". Oxford. 2022-04-28
Quell Therapeutics Ltd.. (4/27/22). "Press Release: Quell Therapeutics and Cellistic Enter a Strategic Collaboration to Develop an iPSC-derived Allogeneic T-regulatory (Treg) Cell Therapy Platform". London & Gosselies. 2022-04-27
Sygnature Discovery Ltd.. (4/26/22). "Press Release: Sygnature Discovery Acquires Peak Proteins, to Strengthen Its Drug Discovery Capabilities". Nottingham. 2022-04-26
BenevolentAI. (4/25/22). "Press Release: BenevolentAI Begins Trading On Euronext Amsterdam". London. 2022-04-25
Euronext N.V.. (4/25/22). "Press Release: BenevolentAI Lists on Euronext Amsterdam. Listed Following Business Combination with Odyssey Acquisition S.A.". Amsterdam. 2022-04-25
MitoRx Therapeutics Ltd.. (4/25/22). "Press Release: MitoRx Therapeutics Announces Seed Financing to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases". Harwell. 2022-04-25
Bayer AG. (4/2122). "Press Release: Bayer Appoints Tara Frenkl as the New Head of Oncology Development at Its Oncology Strategic Business Unit". Berlin. 2022-04-21
CureVac N.V.. (4/21/22). "Press Release: CureVac and GSK’s Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study". Tübingen & Boston, MA. 2022-04-21
Ramarketing. (4/20/22). "Press Release: NorthEdge Invests in Leading Life Sciences Marketing Specialist Ramarketing". 2022-04-20
BioCaptiva Ltd.. (4/13/22). "Press Release: BioCaptiva Appoints Alison Williamson as Chief Financial Officer and Board Director". Edinburgh. 2022-04-13
Oxford BioTherapeutics Ltd.. (4/13/22). "Press Release: Oxford BioTherapeutics Grants Third Exclusive License to Boehringer Ingelheim for Development and Commercialization of Antibody Products to a Novel Oncology Target". Oxford & San Jose, CA. 2022-04-13
GlaxoSmithKline plc. (4/13/22). "Press Release: GSK Reaches Agreement to Acquire Late-stage Biopharmaceutical Company Sierra Oncology for $1.9bn". London. 2022-04-13
Terumo Blood and Cell Technologies. (4/13/22). "Press Release: CEO Antoinette Gawin Will Serve as Group Managing Executive Officer in Terumo Corporation’s New Executive Officers’ Management System". Lakewood, CO. 2022-04-13
Carlyle Group, The. (4/11/22). "Press Release: Carlyle Expands Leading Healthcare Franchise with Agreement to Acquire Life Sciences Investment Firm Abingworth". New York, NY. 2022-04-11
CureVac N.V.. (4/11/22). "Press Release: CureVac and GSK Enter into Pandemic Preparedness Contract with German Government". Tübingen & Boston, MA. 2022-04-11
ReViral Ltd.. (4/7/22). "Press Release: Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates". New York, NY, London & Research Triangle Park, NC. 2022-04-07
Axol Bioscience Ltd.. (4/7/22). "Press Release: Axol Bioscience Raises £3.2 Million GBP (c. $4.2 Million USD)". Cambridge. 2022-04-07
Kynos Therapeutics Ltd.. (4/7/22). "Press Release: Kynos Therapeutics Emerges from Stealth with £9 Million Financing and Phase 1-ready KMO Inhibitor". Edinburgh. 2022-04-07
Catalent, Inc.. (4/6/22). "Press Release: Catalent Acquires Facility in Oxfordshire to Expand Biologics Capabilities in the UK and Across Europe". Somers, NJ. 2022-04-06
Balderton Capital. (4/6/22). "Press Release: Avi Medical Raises €50M to Put Preventative Healthcare and Digital Integration at Heart of Its Service". 2022-04-06
Bruker Corporation. (4/5/22). "Press Release: Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies". Billerica, MA. 2022-04-05
AXA Investment Managers. (4/4/22). "Press Release: AXA IM Alts Launches $500 Million Private Equity Healthcare Strategy alongside Two Senior Appointments". 2022-04-04
Labster ApS. (4/4/22). "Press Release: Labster Secures $47M in New Funding Tranche to Expand Global Opportunities for Virtual Science Laboratory Simulations". Copenhagen & Boston, MA. 2022-04-04
Oxford Gene Technology Ltd.. (4/4/22). "Press Release: OGT Welcomes Adrian Smith as CEO". Oxford. 2022-04-04
LGC Ltd.. (4/1/22). "Press Release: LGC Acquires Rapid Genomics, Bolstering Its Position in the Application of NGS for High-throughput Genotyping Market in AgBio". 2022-04-01
Abzena Ltd.. (3/31/22). "Press Release: Abzena Secures $65 Million in Additional Funding to Accelerate Growth and Expand Capacity". San Diego, CA. 2022-03-31
Oxford Science Enterprises. (3/31/22). "Press Release: Oxford Science Enterprises Strengthens Investment Teams with Two New Appointments". 2022-03-31
CureVac N.V.. (3/30/22). "Press Release: CureVac and GSK Start Clinical Development of Second-generation COVID-19 Vaccine Candidate, CV2CoV". Tübingen & Boston, MA. 2022-03-30
Kadans Science Partner. (3/30/22). "Press Release: Europe’s Largest Commercial Lab Building to Be Built at Canary Wharf, London". 2022-03-30
Argenx SE. (3/29/22). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda. 2022-03-29
Core Biogenesis S.A.S.. (3/29/22). "Press Release: Core Biogenesis Raises €10M from XAnge and Blue Horizon Ventures to Accelerate Treatment of Cancer and Neurodegenerative Diseases". 2022-03-29
XAnge (Alexis du Peloux). (3/29/22). "Press Release (Blog Post): Core Biogenesis – When a Deeptech Goes Faster than Eexpected, Let’s Speed Up!". 2022-03-29
Sano Genetics Ltd.. (3/28/22). "Press Release: Sano Genetics Raises $11M in Funding to Accelerate Genetic Disease Research". 2022-03-28
Argenx SE. (3/23/22). "Press Release: Argenx Raises $700 Million in Gross Proceeds in a Global Offering". Breda. 2022-03-23
Closed Loop Medicine Ltd.. (3/22/22). "Press Release: Closed Loop Medicine Announces Completion of Precision Medicine Clinical Trial for Patients with High Blood Pressure". Cambridge & London. 2022-03-22
Gilde Healthcare Partners. (3/16/22). "Press Release: Gilde Healthcare Raises more than €500 Million for Private Equity Investments in European Healthcare Companies". Utrecht. 2022-03-16
Adrenomed AG. (3/15/22). "Press Release: Adrenomed Supervisory Board Appoints Dr. Richard Jones as CEO". Hennigsdorf. 2022-03-15
SwanBio Therapeutics, Inc.. (3/15/22). "Press Release: FDA Grants Orphan Drug Designation to SBT101, the First Investigational AAV-Based Gene Therapy for Adrenomyeloneuropathy (AMN)". Philadeliphia, PA. 2022-03-15
SeaBeLife S.A.S.. (3/14/22). "Press Release: SeaBeLife Receives Close to €1.4M Deep Tech Financing from Bpifrance". Roscoff. 2022-03-14
Scenic Biotech B.V.. (3/10/22). "Press Release: Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases". Amsterdam. 2022-03-10
Enamine Ltd.. (3/7/22). "Press Release: Open Letter from Enamine Founder and CEO Dr. Andrey Tolmachov". 2022-03-07
LenioBio GmbH. (3/7/22). "Press Release: LenioBio Closes Its Series-A Extension Round and Strengthens Its Board of Directors". Düsseldorf. 2022-03-07
ArrePath. (3/3/22). "Press Release: ArrePath Announces $20 Million Seed Financing to Advance its Machine Learning-based Platform for Discovery of Novel Anti-infectives Addressing Antimicrobial Resistance". Princeton, NJ. 2022-03-03
Epsilogen Ltd.. (3/2/22). "Press Release: Epsilogen Announces Completion of Oversubscribed £30.75 Million ($41.20 Million) Series B Financing". London. 2022-03-02
EQT AB. (3/1/22). "Press Release: EQT Closes Acquisition of LSP and Introduces EQT Life Sciences". 2022-03-01
PhoreMost Ltd.. (3/1/22). "Press Release: PhoreMost Promotes Dr Neil Torbett to Chief Executive Officer". Cambridge. 2022-03-01
Medigene AG. (2/25/22). "Press Release: Dr. Selwyn Ho Appointed New CEO of Medigene". Lisbon. 2022-02-25
Oncodesign S.A.. (2/24/22). "Press Release: Abzena, Alira Health and Oncodesign Launch DRIVE-Biologics to Support Access to Specialist Services from Discovery to Clinical Development for Oncology and Inflammation". Cambridge, Framingham, MA & Dijon. 2022-02-24
Complement Therapeutics Ltd.. (2/23/22). "Press Release: Complement Therapeutics Ltd Raises EUR 5 Million Seed Financing by BGV and Forbion and Appoints Dr Rafiq Hasan as CEO". London. 2022-02-23
Semarion Ltd.. (2/22/22). "Press Release: Semarion Raises £2.14m Seed Funding to Commercialise Cell Assaying Platform". Cambridge. 2022-02-22
Jeito Capital. (2/22/22). "Press Release: Jeito Capital Co-leads $65 Million Series A Financing in EyeBio". Paris. 2022-02-22
Eyebiotech Ldt.. (2/22/22). "Press Release: EyeBio Raises $65M in Series A Funding to Develop New Generation of Eye Disease Therapies". London & New York, NY. 2022-02-22
FZI Forschungszentrum Informatik. (2/21/22). "Press Release: Busy Bees in Search of Data. OCELI Project Makes Causes of Bee Mortality Measurable". Karlsruhe. 2022-02-21
Valneva S.E.. (2/21/22). "Press Release: Valneva Awarded Up to £20 Million by Scottish Enterprise to Advance Vaccine Development". Saint-Herblain. 2022-02-21
Jeito Capital. (2/17/22). "Press Release: Jeito Capital Announces the Appointments of Dr Andreas Wallnöfer as Partner Investor and Isabelle Meyrier as Head of Legal". Paris. 2022-02-17
Centauri Therapeutics Ltd.. (2/16/22). "Press Release: Centauri Therapeutics Closes £24 million GBP Series A Investment Round". London. 2022-02-16
SpliceBio S.L.. (2/16/22). "Press Release: SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline". Barcelona. 2022-02-16
Climedo Health GmbH. (2/16/22). "Press Release: Climedo Closes €5 Million Seed Financing Round". Munich. 2022-02-16
Curve Therapeutics Ltd.. (2/16/22). "Press Release: Curve Therapeutics Announces Collaboration with MSD for Next Generation Drug Discovery Platform". Southampton. 2022-02-16
OxDX Ltd.. (2/15/22). "Press Release: OxDX Raises £2.6M Pre-seed Funding to Develop AI Powered Rapid Diagnostic Technology". Oxford. 2022-02-15
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28  next pagenext page


Picture [iito] Männer Ballett 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top